Suppr超能文献

静脉-静脉途径在小儿急性呼吸衰竭体外膜肺氧合中的主要应用

Primary use of the venovenous approach for extracorporeal membrane oxygenation in pediatric acute respiratory failure.

作者信息

Pettignano Robert, Fortenberry James D, Heard Micheal L, Labuz Michele D, Kesser Kenneth C, Tanner April J, Wagoner Scott F, Heggen Judith

机构信息

Nemours Children's Clinic, Arnold Palmer Hospital for Children and Women, Orlando, FL 32806, USA.

出版信息

Pediatr Crit Care Med. 2003 Jul;4(3):291-8. doi: 10.1097/01.PCC.0000074261.09027.E1.

Abstract

OBJECTIVES

To describe a single center's experience with the primary use of venovenous cannulation for supporting pediatric acute respiratory failure patients with extracorporeal membrane oxygenation (ECMO).

DESIGN

Retrospective chart review of all patients receiving extracorporeal life support at a single institution.

SETTING

Pediatric intensive care unit at a tertiary care children's hospital.

PATIENTS

Eighty-two patients between the ages of 2 wks and 18 yrs with severe acute respiratory failure.

INTERVENTIONS

ECMO for acute respiratory failure.

MEASUREMENTS AND MAIN RESULTS

From January 1991 until April 2002, 82 pediatric patients with acute respiratory failure were cannulated for ECMO support. Median duration of ventilation before ECMO was 5 days (range, 1-17 days). Sixty-eight of these patients (82%) initially were placed on venovenous ECMO. Fourteen patients were initiated and remained on venoarterial support, including six in whom venovenous cannulae could not be placed. One patient was converted from venovenous to venoarterial support due to inadequate oxygenation. Venoarterial patients had significantly greater alveolar-arterial oxygen gradients and lower PaO(2)/FIO(2) ratios than venovenous patients (p <.03). Fifty-five of 81 venovenous patients received additional drainage cannulae (46 of 55 with an internal jugular cephalad catheter). Thirty-five percent of venovenous patients and 36% of venoarterial patients required at least one vasopressor infusion at time of cannulation (p = nonsignificant); vasopressor dependence decreased over the course of ECMO in both groups. Median duration on venovenous ECMO for acute hypoxemic respiratory failure was 218 hrs (range, 24-921). Venovenous ECMO survivors remained cannulated for significantly shorter time than nonsurvivors did (median, 212 vs. 350 hrs; p =.04). Sixty-three of 82 ECMO (77%) patients survived to discharge-56 of 68 venovenous ECMO (81%) and nine of 14 venoarterial ECMO (64%).

CONCLUSIONS

Venovenous ECMO can effectively provide adequate oxygenation for pediatric patients with severe acute respiratory failure receiving ECMO support. Additional cannulae placed at the initiation of venovenous ECMO could be beneficial in achieving flow rates necessary for adequate oxygenation and lung rest.

摘要

目的

描述一家单一中心在主要使用静脉-静脉插管为小儿急性呼吸衰竭患者提供体外膜肺氧合(ECMO)支持方面的经验。

设计

对在单一机构接受体外生命支持的所有患者进行回顾性病历审查。

地点

一家三级儿童医院的儿科重症监护病房。

患者

82例年龄在2周龄至18岁之间的严重急性呼吸衰竭患者。

干预措施

对急性呼吸衰竭进行ECMO治疗。

测量指标及主要结果

从1991年1月至2002年4月,82例急性呼吸衰竭的儿科患者接受了ECMO支持插管。ECMO治疗前的中位通气时间为5天(范围1 - 17天)。其中68例患者(82%)最初接受静脉-静脉ECMO治疗。14例患者开始并持续接受静脉-动脉支持,其中6例无法放置静脉-静脉插管。1例患者因氧合不足从静脉-静脉支持转换为静脉-动脉支持。静脉-动脉支持的患者比静脉-静脉支持的患者具有显著更高的肺泡-动脉氧梯度和更低的PaO₂/FIO₂比值(p < 0.03)。81例静脉-静脉支持患者中有55例接受了额外的引流插管(55例中的46例使用颈内静脉头端导管)。35%的静脉-静脉支持患者和36%的静脉-动脉支持患者在插管时需要至少一种血管升压药输注(p = 无显著差异);两组患者在ECMO治疗过程中血管升压药依赖均有所下降。急性低氧性呼吸衰竭患者接受静脉-静脉ECMO治疗的中位时间为218小时(范围24 - 921小时)。静脉-静脉ECMO治疗存活者的插管时间显著短于未存活者(中位时间,212小时对350小时;p = 0.04)。82例接受ECMO治疗的患者中有63例(77%)存活至出院——68例接受静脉-静脉ECMO治疗的患者中有56例(81%),14例接受静脉-动脉ECMO治疗的患者中有9例(64%)。

结论

静脉-静脉ECMO可为接受ECMO支持的小儿严重急性呼吸衰竭患者有效提供充足的氧合。在开始静脉-静脉ECMO治疗时放置额外的插管可能有助于实现充足氧合和肺休息所需的流速。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验